Ian M Adcock, ERS 2018 – Severe asthma in adults and children
Editorial board member Ian Adcock (Imperial College, London, UK) shares his views on the most challenging aspects surrounding the management of adults and children with severe asthma, as well as discussing the U-BIOPRED (Unbiased BIOmarkers in PREDiction of respiratory disease outcomes) study and promising novel therapeutic targets currently in clinical development.
1. What are the most challenging aspects of the management of adults and children with severe asthma? (0:12)
2. Could you tell us a little about the objectives of the U-BIOPRED (Unbiased BIOmarkers in PREDiction of respiratory disease outcomes) study? (0:45)
3. Of which of the study’s accomplishments are you most proud? (1:42)
4. How can the identification of phenotypes of severe asthma help in the treatment of the disease? (2:32)
5. What are the most promising novel therapeutic targets in clinical development? (3:44)
Speaker disclosure: Ian M Adcock has nothing to disclose in relation to this video interview.
Filmed at the European Respiratory Society (ERS) International Congress 2018, Paris, France, September 2018.
Share this Video
Related Videos In Asthma
Isaac Schmale, AAAAI 2023: Efficacy of dupilumab for nasal polyposis in patients with aspirin-exacerbated respiratory disease
Dupilumab is used to manage chronic rhinosinusitis with nasal polyposis, however there is limited data regarding its use in patients with aspirin-exacerbated respiratory disease (AERD). touchRESPIRATORY caught up with Dr Isaac Schmale (University of Rochester Medical Center, Rochester, NY, USA) around the aims, eligibility, methodology and findings of his study investigating the real-world outcomes of […]
Isaac Schmale, AAAAI 2023: Signs and symptoms of aspirin-exacerbated respiratory disease and its treatment paradigm
touchRESPIRATORY were delighted to speak with Dr Isaac Schmale (University of Rochester Medical Center, Rochester, NY, USA) around the signs and symptoms of aspirin-exacerbated respiratory disease (AERD), the incidence of AERD in people with asthma, the current treatment paradigm for AERD and the unmet needs in its treatment. The abstract ‘Real-world Outcomes of Dupilumab Therapy […]
Ronald Strauss, AAAAI 2023: Hot topics to explore in the field of respiratory medicine
touchRESPIRATORY were delighted to speak with a valued member of our Editorial Board for touchREVIEWS in Respiratory & Pulmonary Diseases, Dr Ronald Strauss (Case Western Reserve University; Cleveland Allergy and Asthma Center, Cleveland, OH, USA), about the areas in the field of respiratory medicine that he is most looking forward to exploring in 2023. Questions […]
Journal articles and more to your inbox
Get the latest clinical insights from touchRESPIRATORYSign me up!